⚖️US ITC Notice
Certain Products Containing Tirzepatide and Products Purporting To Contain Tirzepatide; Notice of a Commission Determination Not To Review an Initial Determination Finding Respondents in Violation of Section 337; Request for Written Submissions on Remedy, the Public Interest, and Bonding
Summary
Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined not to review an initial determination ("ID") (Order No. 26) of the presiding administrative law judge ("ALJ"), partially granting a motion for summary determination on violation of section 337. The Commission requests written submissions from the parties, interested government agencies, and other interested persons on the issues of remedy, the public interest, and bonding, under the schedule set forth below.
Agencies
- International Trade Commission
Business Impact
$$ - Med
The text details a ruling by the U.S. International Trade Commission regarding violations relating to tirzepatide products, which can impact importers and businesses involved in the manufacture and sale of these goods. The potential for exclusion orders and cease and desist orders indicates possible financial repercussions and compliance requirements for affected businesses.